Table 1.
Baseline characteristics for cardiovascular disease (CVD) patients at first measurement in strata of presence of repeated measurements.
| Characteristic | No repeated measurements (N=13,161) | Repeated measurements (N=10,771) | |
| Women, n (%) | 4257 (32.35) | 3254 (30.21) | |
| Age (years), mean (SD) | 65.5 (12.8) | 60.8 (12.1) | |
| Smoking (current), n (%) | 1523 (11.57) | 967 (8.98) | |
| LDL-ca (mmol/L), median (IQR) | 2.4 (1.9-3.1) | 2.4 (1.9-3.1) | |
| Systolic blood pressure (mmHg), mean (SD) | 137.5 (23.5) | 135.3 (23.2) | |
| Diastolic blood pressure (mmHg), mean (SD) | 76.3 (13.5) | 77.5 (13.7) | |
| Diabetes, n (%) | 1456 (11.06) | 1415 (13.14) | |
| Hypertension, n (%) | 4428 (33.64) | 3514 (32.62) | |
| Chronic kidney disease, n (%) | 43 (0.33) | 108 (1.00) | |
| Prevalent CVD, n (%) |
|
|
|
|
|
Coronary heart disease | 9313 (70.76) | 7660 (71.11) |
|
|
Stroke | 2912 (22.13) | 1929 (17.91) |
|
|
Peripheral artery disease | 1461 (11.10) | 1791 (16.63) |
|
|
Abdominal aortic aneurysm | 502 (3.81) | 503 (4.67) |
| Registered medication, n (%) |
|
|
|
|
|
Statin | 4616 (35.07) | 3368 (31.27) |
|
|
Other lipid lowering | 59 (0.45) | 32 (0.30) |
|
|
Blood pressure lowering | 5690 (43.23) | 4193 (38.93) |
|
|
Glucose lowering | 1065 (8.09) | 685 (6.36) |
|
|
Antithrombotic | 5863 (44.55) | 4329 (40.19) |
aLDL-c: low-density lipoprotein cholesterol.